Trial intelligence / Profile preview

Tranexamic Acid in Reduction Mammaplasty

NCT07131592Phase 4Recruiting

Sponsor
Massachusetts General Hospital
Start
Nov 2025
Primary completion
Mar 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid in Breast hypertrophy, sponsored by Massachusetts General Hospital. Started Nov 2025; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

Breast hypertrophy

Beyond the preview

Go deeper on NCT07131592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07131592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call